Driven by evidence
Experience flow diversion simplified with the
Surpass Evolve™
Flow Diverter
Designed for ease of use and optimized flow diversion, the Surpass Evolve Flow Diverter has been demonstrating strong efficacy and favorable safety data in the treatment of unruptured intracranial aneurysms around the world.
Selected occlusion rates around the world
Use the links below to learn more
N indicates the total patient population enrolled in the study.
* Complete occlusion rate (RROC 1)
** Complete occlusion rate (OKM D)
† Favorable occlusion rate (OKM C-D)
‡ Favorable occlusion rate (RROC 1+2)
§ This investigator initiated study was wholly or in part by Stryker. The funding source was not involved in study design, monitoring, data collection, statistical analysis, interpretation of results, or manuscript writing.
We are driven by clinical evidence and committed to proving the safety and effectiveness of our products in treating the toughest stroke cases.
Contact us
Thank you!
1. Bibi R, Bankole NDA, Donnard B, et al. Safety and efficacy of Surpass Evolve Flow diverter for intracranial aneurysms: A study of 116 patients. Neuroradiol J. 2024;37(2):184-191. doi:10.1177/19714009231224408
2. Vivanco-Suarez J, Dibas M, Lopes DK, et al. Safety and effectiveness assessment of the surpass evolve (SEASE): a post-market international multicenter study. J Neurointerv Surg. Published online April 25, 2024. doi:10.1136/jnis-2024-021503
3. Hyun J. HAN, Joonho CHUNG, Chang K. JANG, Jung-Jae KIM, Keun Y. PARK and Yong B. KIM (2023). One-year clinical and radiologic outcomes of Surpass Evolve flow diverter forlarge unruptured intracranial aneurysms. Journal of Neurosurgical Sciences. 10.23736/S0390-5616.23.06161-1.
4. Sayin, B., Dereli, B., Senol, Y. C., Akmangit, I., Karaman, A., Daglioglu, E., & Belen, A. D. (2023). The Evaluation of Low-Profile Surpass EvolveTM Flow Diverter for Endovascular Treatment of Distal Cerebral Artery Aneurysms: A Single-Center Experience. Turkish neurosurgery, 33(3), 477–487. https://doi.org/10.5137/1019-5149.JTN.42071-22.1
5. Gupta G, Sreenivasan S, Baek SW, et al. Does Small Aneurysm Size (<10 mm) Predict Complete Occlusion After Flow Diversion? A Surpass Evolve Single-Center Study. J Endovasc. Published online March 29, 2024. doi:10.1177/15266028241240943
6. Rautio, R., Alpay, K., Sinisalo, M., & Numminen, J. (2022). Treatment of intracranial aneurysms using the new Surpass Evolve flow diverter: Safety outcomes and six-month imaging follow-up. Journal of neuroradiology = Journal de neuroradiologie, 49(1), 80–86. https://doi.org/10.1016/j.neurad.2021.03.003
7. Maus, V., Weber, W., Berlis, A., Maurer, C., & Fischer, S. (2021). Initial Experience with Surpass Evolve Flow Diverter in the Treatment of Intracranial Aneurysms. Clinical neuroradiology, 31(3), 681–689. https://doi.org/10.1007/s00062-020-00972-5
This document is intended solely for the use of healthcare professionals.
A physician must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that physicians be trained in the use of any particular product before using it in a procedure. The information presented is intended to demonstrate the breadth of Stryker product offerings. A physician must always refer to the package insert, product label and/or instructions for use before using any Stryker product. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area.
Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Stryker, Surpass Evolve. All other trademarks are trademarks of their respective owners or holders.
The absence of a product, feature, or service name, or logo from this list does not constitute a waiver of Stryker’s trademark or other intellectual property rights concerning that name or logo.
AP004736 v1.0